{"grounding": "Osteoclasts are multinucleated cells with the unique ability to resorb bone matrix. Excessive production or activation of osteoclasts leads to skeletal pathologies that affect a significant portion of the population. Although therapies that effectively target osteoclasts have been developed, they are associated with sometimes severe side effects, and a fuller understanding of osteoclast biology may lead to more specific treatments. Along those lines, a rich body of work has defined essential signaling pathways required for osteoclast formation, function, and survival. Nonetheless, recent studies have cast new light on long-held views regarding the origin of these cells during development and homeostasis, their life span, and the cellular sources of factors that drive their production and activity during homeostasis and disease. In this review, we discuss these new findings in the context of existing work and highlight areas of ongoing and future investigation.", "generated_text": "Osteoclasts, the primary bone-resorbing cells, play a critical role in the dynamic process of bone remodeling. These multinucleated giant cells are derived from hematopoietic precursors and are essential for maintaining bone homeostasis. Osteoclastogenesis, the differentiation and activation of osteoclasts, is tightly regulated by a complex interplay of cytokines and signaling pathways, including RANKL, M-CSF, and osteoprotegerin. Dysregulation of these processes can lead to pathological conditions such as osteoporosis, osteolytic lesions, and Paget\u2019s disease. Recent advances in understanding the molecular mechanisms underlying osteoclast function have highlighted the importance of these cells in both physiological and pathological bone resorption. This review summarizes the current knowledge on osteoclast biology, focusing on their role in bone remodeling and the potential therapeutic targets for osteolytic diseases.", "label": 1}